UPDATE ON ANTITHROMBOTIC AGENTS IN SECONDARY STROKE PREVENTION

被引:0
|
作者
Rundek, Tatjana [2 ]
Basic-Kes, Vanja [1 ]
Morovic, Sandra [1 ]
Demarin, Vida [1 ]
机构
[1] Sestre Milosrdnice Univ Hosp Ctr, Croatian Acad Sci & Arts Vida Demarin, Univ Dept Neurol, Reference Ctr Neurovasc Disorders & Headache,Mini, Zagreb 10000, Croatia
[2] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA
关键词
Stroke; prevention and control; Secondary prevention; Platelet aggregation inhibitors; therapeutic use; Anticoagulants; TRANSIENT ISCHEMIC ATTACK; ATRIAL-FIBRILLATION; CEREBRAL INFARCTION; DOUBLE-BLIND; ASPIRIN; CLOPIDOGREL; WARFARIN; RISK; DIPYRIDAMOLE; PREDICTORS;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recurrent stroke is a major cause of morbidity and mortality among stroke survivors. With improved survival after first ischemic stroke, stroke recurrence may account for a greater share of the future annual cost of stroke-related health care. Despite advances in stroke prevention strategies and treatments, stroke recurrence is still the major threat to any stroke survivor. This review discusses antithrombotic therapy in secondary stroke prevention which has a major impact in clinical practice.
引用
收藏
页码:101 / 106
页数:6
相关论文
共 50 条